Cargando…
The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors
INTRODUCTION: Tumor necrosis factor-alpha (TNFα) inhibitors have significantly improved the outcomes of treatment for rheumatoid arthritis (RA). In the present study, we aimed to determine whether serum levels of TNFα during therapy with TNFα inhibitors do really reflect the disease activity and cor...
Autores principales: | Sikorska, Dorota, Kawka, Edyta, Rutkowski, Rafał, Samborski, Włodzimierz, Witowski, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663924/ https://www.ncbi.nlm.nih.gov/pubmed/30675683 http://dx.doi.org/10.1007/s10787-019-00564-x |
Ejemplares similares
-
No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018) -
Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018) -
Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites
por: Witoszyńska-Sobkowiak, Joanna, et al.
Publicado: (2023) -
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
por: Sikorska, Dorota, et al.
Publicado: (2018) -
TNF-α inhibitors: are they carcinogenic?
por: Raval, Girindra, et al.
Publicado: (2010)